FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3 letters match. Newest first.

  1. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  2. Kimera Labs, Inc.

    FDA warns Kimera Labs over unapproved exosome and amniotic fluid products and serious sterile manufacturing failures.

    High risk
  3. BioLab Sciences, Inc.

    FDA warned BioLab Sciences that its injected amniotic fluid and skin products were unapproved biologics with serious manufacturing violations.

    High risk